Article Listing - Abbott fined by FDA over quality control, Alza merger under threat

ARTHRITIS "NEGLECTED" IN THE UK

16 March 1992

Although arthritis is estimated to affect about 20 million people in the UK, it is considered a neglected disease. Furthermore,...

NEW PRODUCT PHASE FOR BRITISH BIO-TECH

16 March 1992

British-biotechnology Group will look back on 1991 as a milestone year in the company's history, according to chairman Brian Richards,...

UPJOHN "DOWNGRADE"

16 March 1992

Because of concerns regarding side effects and their impact on the sales of Upjohn's sedative Halcion (triazolam), now around $260...

ITALY'S MENARINI TO INVEST ABROAD

16 March 1992

Italian pharmaceutical concern Menarini has given up on its scheme to set up a plant on the island of Elba,...

STOCK MARKET COMMENTARY: TOKYO

16 March 1992

TOKYO: stocks declined in a narrow trading range last week. Although volume remained low, the market did not have enough...

STOCK MARKET COMMENTARY: EUROPE

16 March 1992

EUROPE: was mixed last week, with strong performance in Sweden and a poor one in Italy, where Pierrel was...

ROUSSEL-UCLAFS MIFEGYNE

16 March 1992

- Roussel-Uclaf's progesterone antagonist abortifacient product Mifegyne (mifepristone) is to be tested as a first-line therapy for breast cancer in...

KANEBO MONOCLONAL ANTIBODIES

16 March 1992

- Japanese diversified textile and cosmetics company Kanebo Ltd plans to introduce technology for a humanized monoclonal antibody, the Smart...

GOOD GROWTH FOR RHONE-POULENC

9 March 1992

At Rhone-Poulenc, "the aggressive marketing effort on promotion-responsive products, supplemented by a roll-out of at least eight new medium-sized drugs,...

PHARMA OFFSETS SHARP FALL AT AKZO

9 March 1992

The Dutch chemical and pharmaceutical group, Akzo, saw declines in 1991, but buoyant pharmaceuticals helped to offset poor results in...

Showing 94631-94640 of 95316 articles